TissueGen to Showcase ELUTE® Fiber for Nerve Regeneration, Tissue Engineering and Advanced Drug Delivery at Neuroscience 2016

01 Nov TissueGen to Showcase ELUTE® Fiber for Nerve Regeneration, Tissue Engineering and Advanced Drug Delivery at Neuroscience 2016

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

WHAT: TissueGen, Inc. will showcase ELUTE® fiber for advanced pharmaceutical and biologics delivery from biodegradable polymers in Booth 3013 at the Society for Neuroscience’s Neuroscience 2016 meeting. ELUTE fiber directly replaces traditional fibers in medical textiles to potentially improve clinical outcomes by delivering temperature sensitive therapeutics and live biologics directly at the site of implant.

At Neuroscience 2016, explore how TissueGen’s patented manufacturing process enables controlled sustained delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics ever possible via biodegradable fiber-based devices to enable medical device developers to achieve breakthroughs across a broad range of medical applications.

To set up a meeting, please contact Christopher Knowles at cknowles@tissuegen.com or 1.214.351.1922.

WHERE:
Neuroscience 2016
Booth 3013
San Diego Convention Center
111 West Harbor Drive
San Diego, CA 92101

WHEN: Neuroscience 2016 will take place November 12-16, 2016.

To schedule a briefing, please contact Jordan Bouclin at Jordan.bouclin@svmpr.com or 1.401.490.9700.

About TissueGen

TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has more than four decades of cumulative experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

 

For more information contact:

Jordan Bouclin
SVM Public Relations
1.401.490.9700
jordan.bouclin@svmpr.com

No Comments

Sorry, the comment form is closed at this time.